MPD: Measures involving pilocarpine

Sort/ Pick	Data set	Procedure / Protocol	Drug or Challenge	Phenotype Measure	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Schauwecker1:1	Schauwecker1	health assessment	pilocarpine	pilocarpine dose required to induce status epilepticus, mg/kg body weight [mg/kg] ED100 47701	inbred	8	m	8-10wks	N=4	2012

Schauwecker1:2	Schauwecker1	health assessment	pilocarpine	latency to onset of stage 4 status epilepticus seizures [min] latency 47702	inbred	8	m	8-10wks	N=4	2012

Schauwecker1:3	Schauwecker1	health assessment	pilocarpine	duration of stage 4 status epilepticus seizures [min] duration 47703	inbred	8	m	8-10wks	N=4	2012

Schauwecker1:4	Schauwecker1	health assessment	pilocarpine	status epilepticus seizure mortality (0=died; 1=survived) [designation] survival 47704	inbred	11	m	8-10wks	N=18	2012

Schauwecker1

health assessment

pilocarpine

inbred

8

m

8-10wks

N=4

2012

Schauwecker1

health assessment

pilocarpine

latency to onset of stage 4 status epilepticus seizures [min] latency 47702

inbred

8

m

8-10wks

N=4

2012

Schauwecker1

health assessment

pilocarpine

duration of stage 4 status epilepticus seizures [min] duration 47703

inbred

8

m

8-10wks

N=4

2012

Schauwecker1

health assessment

pilocarpine

status epilepticus seizure mortality (0=died; 1=survived) [designation] survival 47704

inbred

11

m

8-10wks

N=18

2012